Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9216759 | Oral Oncology | 2005 | 7 Pages |
Abstract
Serum levels of IL-8 are consistently elevated in patients with recurrent or metastatic SCCHN and elevated levels may correlate with advanced or aggressive disease. Further, more intensive, study of IL-8 as a biomarker in SCCHN is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Abhay S. Gokhale, Robert I. Haddad, Lisa A. Cavacini, Lori Wirth, Linda Weeks, Melissa Hallar, Jarrod Faucher, Marshall R. Posner,